Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1515480 | 0.81 | HDAC3 (0.37) | LMNA | |
| SCHEMBL13544805 | 0.78 | MCL1 (0.36) | MCL1LMNA | |
| SCHEMBL13544539 | 0.78 | TSHR (0.39) | MCL1LMNA | |
| SCHEMBL27417493 | 0.77 | MCL1 (0.32) | MCL1LMNA | |
| SCHEMBL1515459 | 0.77 | — | — | |
| SCHEMBL6944057 | 0.75 | — | — | |
| SCHEMBL14167250 | 0.74 | MCL1 (0.33) | MCL1LMNA | |
| SCHEMBL1515653 | 0.74 | CNR1 (0.35) | LMNA | |
| SCHEMBL960674 | 0.74 | KDM4E (0.40) | LMNA | |
| SCHEMBL681118 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3621619-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VISCERAL PAIN | Arena Pharmaceuticals, Inc. (US) | 2020-03-18 | — | — | EP | claimed |
| WO-2018208848-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VISCERAL PAIN | ARENA PHARMACEUTICALS, INC. (US) | 2018-11-15 | — | — | WO | claimed |
| WO-2018208847-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF PAIN FROM INFLAMMATORY BOWEL DISEASE | ARENA PHARMACEUTICALS, INC. (US) | 2018-11-15 | — | — | WO | claimed |
| EP-2928867-A1 | PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS | F. Hoffmann-La Roche AG (CH) | 2015-10-14 | — | — | EP | claimed |
| EP-2771327-A1 | NOVEL PYRAZINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2014-09-03 | — | — | EP | claimed |
| WO-2014086805-A1 | PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-06-12 | — | — | WO | claimed |
| WO-2013060751-A1 | NOVEL PYRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2013-05-02 | — | — | WO | claimed |
| EP-2470508-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2012-07-04 | — | — | EP | claimed |
| EP-1532132-A1 | NOVEL BENZODIOXOLES | F.HOFFMANN-LA ROCHE AG (CH) | 2005-05-25 | — | — | EP | claimed |
| US-6818622-B2 | ADMINISTERING OVER A PERIOD OF AT LEAST THREE MONTHS A MATRIX METALLOPROTEINASE INHIBITOR FOR TREATMENT OF A PATIENT HAVING CANCER OR INFLAMMATION | DARWIN DISCOVERY LTD. (GB) | 2004-11-16 | — | — | US | claimed |
| EP-0981366-B1 | SELECTIVE MMP INHIBITORS HAVING REDUCED SIDE-EFFECTS | DARWIN DISCOVERY LTD (GB) | 2004-01-21 | — | — | EP | claimed |
| US-20020173530-A1 | Single morphic forms of metalloproteinase inhibitors | KATZ RUTH BERNICE (GB) | 2002-11-21 | — | — | US | claimed |
| US-20020035065-A1 | Selective MMP inhibitors having reduced side-effects | BIRD JOHN (GB) | 2002-03-21 | — | — | US | claimed |
| US-20020025980-A1 | Single morphic forms of metalloproteinase inhibitors | KATZ RUTH BERNICE (GB) | 2002-02-28 | — | — | US | claimed |
| US-6277827-B1 | Single morphic forms of metalloproteinase inhibitors | DARWIN DISCOVERY, LTD. (GB) | 2001-08-21 | — | — | US | claimed |
| EP-1123308-A1 | SINGLE MORPHIC FORMS OF KNOWN PEPTIDE METALLOPROTEINASE INHIBITORS | Darwin Discovery Limited (GB) | 2001-08-16 | — | — | EP | claimed |
| WO-2000024763-A1 | SINGLE MORPHIC FORMS OF KNOWN PEPTIDE METALLOPROTEINASE INHIBITORS | DARWIN DISCOVERY LIMITED (GB) | 2000-05-04 | — | — | WO | claimed |
| EP-0763012-B1 | SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1999-06-09 | — | — | EP | claimed |
| EP-0763012-A1 | SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1997-03-19 | — | — | EP | claimed |
| WO-1995032944-A1 | SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-12-07 | — | — | WO | claimed |